IL139310A0 - Process for the preparation of methyl(2s)-2-[(3r)-3-(n-[tertbutyloxycarbontl]-amino)-2-oxopyrro propionate - Google Patents

Process for the preparation of methyl(2s)-2-[(3r)-3-(n-[tertbutyloxycarbontl]-amino)-2-oxopyrro propionate

Info

Publication number
IL139310A0
IL139310A0 IL13931099A IL13931099A IL139310A0 IL 139310 A0 IL139310 A0 IL 139310A0 IL 13931099 A IL13931099 A IL 13931099A IL 13931099 A IL13931099 A IL 13931099A IL 139310 A0 IL139310 A0 IL 139310A0
Authority
IL
Israel
Prior art keywords
propionate
amino
methyl
tertbutyloxycarbontl
oxopyrro
Prior art date
Application number
IL13931099A
Other languages
English (en)
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Publication of IL139310A0 publication Critical patent/IL139310A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
    • C07C323/23—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton
    • C07C323/24—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton
    • C07C323/25—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being acyclic and saturated
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/18—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D207/22—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/24—Oxygen or sulfur atoms
    • C07D207/26—2-Pyrrolidones
    • C07D207/273—2-Pyrrolidones with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to other ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06139—Dipeptides with the first amino acid being heterocyclic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pyrrole Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Physical Or Chemical Processes And Apparatus (AREA)
IL13931099A 1998-04-29 1999-04-27 Process for the preparation of methyl(2s)-2-[(3r)-3-(n-[tertbutyloxycarbontl]-amino)-2-oxopyrro propionate IL139310A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9809021.0A GB9809021D0 (en) 1998-04-29 1998-04-29 Chemical process
PCT/GB1999/001307 WO1999055669A1 (en) 1998-04-29 1999-04-27 Process for the preparation of methyl(2s)-2-[(3r)-3-(n-[tert-butyloxycarbonyl]-amino)-2-oxopyrrolidin-1-yl]propionate

Publications (1)

Publication Number Publication Date
IL139310A0 true IL139310A0 (en) 2001-11-25

Family

ID=10831089

Family Applications (1)

Application Number Title Priority Date Filing Date
IL13931099A IL139310A0 (en) 1998-04-29 1999-04-27 Process for the preparation of methyl(2s)-2-[(3r)-3-(n-[tertbutyloxycarbontl]-amino)-2-oxopyrro propionate

Country Status (16)

Country Link
US (1) US6248903B1 (de)
EP (1) EP1076645B1 (de)
JP (1) JP2002513000A (de)
KR (1) KR20010043046A (de)
CN (1) CN1298387A (de)
AT (1) ATE260892T1 (de)
AU (1) AU3719199A (de)
BR (1) BR9910014A (de)
CA (1) CA2327363A1 (de)
DE (1) DE69915274T2 (de)
GB (1) GB9809021D0 (de)
IL (1) IL139310A0 (de)
NO (1) NO20005410L (de)
NZ (1) NZ506954A (de)
WO (1) WO1999055669A1 (de)
ZA (1) ZA200005302B (de)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0130285D0 (en) 2001-12-19 2002-02-06 Astrazeneca Ab Chemical process

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3723534A (en) * 1971-05-28 1973-03-27 Monsanto Co Aryl methyl phenacyl sulfonium tetrafluoroborates
US4377515A (en) 1979-10-01 1983-03-22 Merck & Co., Inc. Long lasting agonists and antagonists of LH-RH
AU7604196A (en) 1995-10-30 1997-05-22 Merck & Co., Inc. Novel inhibitors of peptide binding to mhc class ii proteins
GB9702377D0 (en) 1996-02-23 1997-03-26 Zeneca Ltd Peptide derivatives
IL127332A0 (en) * 1996-06-07 1999-09-22 Zeneca Ltd Peptide derivatives
GB9624562D0 (en) 1996-11-27 1997-01-15 Zeneca Ltd Peptide derivatives

Also Published As

Publication number Publication date
ATE260892T1 (de) 2004-03-15
CN1298387A (zh) 2001-06-06
WO1999055669A1 (en) 1999-11-04
ZA200005302B (en) 2001-10-01
JP2002513000A (ja) 2002-05-08
BR9910014A (pt) 2001-01-09
NZ506954A (en) 2003-06-30
GB9809021D0 (en) 1998-06-24
DE69915274D1 (de) 2004-04-08
NO20005410D0 (no) 2000-10-27
EP1076645A1 (de) 2001-02-21
CA2327363A1 (en) 1999-11-04
US6248903B1 (en) 2001-06-19
EP1076645B1 (de) 2004-03-03
AU3719199A (en) 1999-11-16
KR20010043046A (ko) 2001-05-25
DE69915274T2 (de) 2005-02-24
NO20005410L (no) 2000-12-21

Similar Documents

Publication Publication Date Title
AU6293001A (en) Reaction systems for making n-(phosphonomethyl)glycine compounds
ID28070A (id) Kalsium (3s) tetrahidro-3-furanil (1s,2r)-3-((4-aminofenil) sulfonil) (isobutil) amino)-1-benzil-2-(fosfonooksi) propilkarbamat
MXPA03005219A (es) Peptidos diarilicos como inhibidores de ns3-serina proteasa en hepatitis de virus c.
NZ296479A (en) Amino acid or peptide derivatives which are inhibitors of multicatalytic protease (mcp)
EP0987332A4 (de) Verfahren zur herstellung optisch aktiver aminoverbindungen
HU9603237D0 (en) Kristalline hydrochloride of (r)-(-)-2-{n-[4-(1,1-dioxydo-3-oxo-2,3-dihydro-benzisothiazo-2-yl)-butyl]-amino-methyl}-chromane
ZA200205409B (en) Process for rapid solution synthesis of peptides.
BG104243A (en) Method for the synthesis of quinoline derivatives
AU4300497A (en) Process for the manufacture of aliphatic alpha, omega amino nitriles
IL139310A0 (en) Process for the preparation of methyl(2s)-2-[(3r)-3-(n-[tertbutyloxycarbontl]-amino)-2-oxopyrro propionate
ZA99939B (en) Process for the preparation of 2-aryl-5-(perfluoroalkyl) pyrrole compounds from N-(perfluoroalkylmethyl) arylimidoyl chloride compounds.
IL132623A0 (en) Process for making 2-(trihaloacetyl)-3-(substituted amino)-2-propenoates
DK1257557T3 (da) Fremgangsmåde til fremstilling af N-(phosphonomethyl)glycin
IL138127A (en) Process for the synthesis of hiv protease inhibitors
WO2001083518A3 (en) Molecules that modulate ubiquitin-dependent proteolysis and methods for identifying same
AU2003247758A1 (en) Methods for treating alzheimer's disease using hydroxyethylene compounds containing a heterocyclic amide bond isostere
CA2276318A1 (en) Process for s-aryl-cysteine and derivatives
IL138843A0 (en) Improved process for the manufacture of n- (1-cyanoalkyl) -2-phenoxypropionamide derivatives
HK1057040A1 (en) Process and intermediates for preparing retroviralprotease inhibitors
MX9801636A (es) Procedimiento para la preparacion de un tiazol disubstituido.
ZA9811238B (en) Process for the preparation of isopropyl-methyl-(2-(3-n-propoxyphenoxy)ethyl)amine
HUP0301223A3 (en) Process for purifying n2-(1(s)-ethoxycarbonyl-3-phenylpropyl)-n6-trifluoroacetyl-l-lysine
NO984490L (no) FremgangsmÕte for fremstilling av N-metyl-D-fenylalanyl-N-[1-[3-[(aminoiminometyl)amino]propyl]-3,3-difluor-2-okso-heksyl]-L-prolinamid
DK1104427T3 (da) Fremgangsmåde til fremstillingen af N-(phosphonomethyl)glycin ved oxidation af N-substitueret N-(phosphonomethyl)glycin
EP1236715A3 (de) Verfahren zur Herstellung von S-Aryl-Cystein